cancer-patient Downloads
10 downloads found
To date, the classification of cancers has been based solely on the phenotypic and genotypic characteristics of tumor cells. A new paradigm, scientifically well established and recommended by WHO guidelines, relies on the introduction of the immune response as a new prognostic parameter to predict and refine the clinical outcomes of cancer patients. Maximize patient survival rates with an ...
ByVeracyte
Junction Adhesion Molecule C (JAM-C) has been studied at the laboratories of Prof. Beat Imhof and Prof. Thomas Matthes at the Université de Genève for over 10+ years (36 peer reviewed publications). There is in addition 60+ publications from other laboratories. JAM-C is expressed by certain lymphocytes and prominently localises to tight junctions of endotelial cells. In many ...
ByAbologix
Olfactomedin-like protein 3 (Olfml3) creates an angiogenic environment in tumours and is associated with vascular growth factors BMP-4 and PDGF. Olfml3 is overexpressed in some cancers. Blocking Olfml3 with highly specific monoclonal antibodies is therefore a logical scientific approach in order to develop new generation inhibitors of angiogenesis. Abologix has produced several recombinant ...
ByAbologix
A tool that performs in silico clinical trials to assess the neutropenic effects of a chemotherapeutic agent in a virtual population of cancer patients ...
It is our goal to help you deliver the best possible radiotherapy, for every patient, every time. Designed in collaboration with industry-leading experts and world-renowned cancer research institutions, Elekta Unity—our breakthrough MR-Linac technology— positions you at the forefront of patient-centric cancer ...
PCa GnRH Agonists Simulator enables simulations of clinical trials on a virtual population of prostate cancer patients being treated with a GnRH agonist ...
OncoSELECT: Smart liquid biopsy panels with selected key genes per tumor type. The Liquid Biopsy Solution For Disease Monitoring Or Therapeutic Decision. OncoSELECT is a fast and minimally invasive analysis of circulating tumor DNA from a blood sample for lung (NSCLC), colorectal and breast (HR+ or HER2+) cancer patients. It is the perfect solution to identify therapeutic options for cancer ...
Use our immune-oncology IVD solutions IMMUNOSCORE in Localized Colon Cancer and IMMUNOSCORE IC in Non-Small Cell Lung Cancer to improve patient care management with immune contexture ...
ByVeracyte
Our flagship product—the Intraop® Mobetron®—is used by the leading cancer physicians in the best hospitals, clinics and academic centers in the world. The Mobetron is the first mobile, self-shielded electron-beam linear accelerator (LINAC) machine designed to deliver Intraoperative Radiation Therapy (IORT) to cancer patients during surgery. This innovation brings safe, ...
Providing risk-assessment for hereditary cancer syndromes for patients and their families. xG+ (extended hereditary cancers): Covers genes associated with multiple hereditary cancer types, including common hereditary cancers (breast, ovarian, colorectal, endometrial, prostate, pancreatic) and others (renal/urinary tract, gastric, melanoma, thyroid, endocrine, sarcomas, central nervous system, ...
ByTempus